CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 79% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
US English

Avacta (AVCT) stock up after EU approves Covid test

By Angela Barnes

09:51, 22 December 2021

A Covid-19 testing laboratory
Avacta’s lateral flow test has been approved for use in the UK and Europe – Photo: Shutterstock.

Avacta stock was up 18.32% on the London Stock Exchange on Wednesday morning after the company’s Covid-19 rapid test was approved for use in the UK and European Union.

In a statement published on Wednesday, the clinical-stage biopharmaceutical company said its AffiDX®SARS-CoV-2 antigen lateral flow test had received a regulatory CE mark for use as a consumer self-test.

“Avacta partnered with Medusa Healthcare (‘Medusa’) to obtain regulatory approval for the AffiDX® antigen test for consumer self-testing and has now received the CE mark from a European Notified Body. Avacta has an exclusive arrangement with Medusa to commercialise the consumer self-test product globally,” the group said.

New test brand name

It also noted that its lateral flow self-test will be sold under the brand name ‘MeduFlow’.

The company highlighted that the test has been developed using Avacta’s proprietary Affimer® platform to identify individuals with a higher viral load of the SARS-CoV-2 virus and are more likely to infect others.

The test, which uses a nasal swab and gives a result in 20 minutes, has been independently clinically validated at the Carlos III hospital in Madrid, Avacta said.

COIN

127.75 Price
+6.400% 1D Chg, %
Long position overnight fee -0.0262%
Short position overnight fee 0.0040%
Overnight fee time 22:00 (UTC)
Spread 0.12

TSLA

249.42 Price
+5.620% 1D Chg, %
Long position overnight fee -0.0262%
Short position overnight fee 0.0040%
Overnight fee time 22:00 (UTC)
Spread 0.18

VODl

0.72 Price
-0.490% 1D Chg, %
Long position overnight fee -0.0253%
Short position overnight fee 0.0033%
Overnight fee time 22:00 (UTC)
Spread 0.0125

NVDA

477.93 Price
-0.860% 1D Chg, %
Long position overnight fee -0.0262%
Short position overnight fee 0.0040%
Overnight fee time 22:00 (UTC)
Spread 0.23

The biopharm business also noted that the test has shown to have a sensitivity across a broad range of viral loads of 98% and a specificity of 99%.

CEO comments on the approval

Dr Alastair Smith, Avacta Group CEO, commented on the development.

“This is an extremely important step forwards in the commercialisation of the AffiDX® antigen test. As the pandemic progresses, the global antigen testing market is moving away from professional use antigen tests with increasing adoption of self-test products,” he said. 

“The AffiDX® test is the first UK-developed SARS-CoV-2 antigen test that has received a CE mark for self-testing which, coupled with the fact that it is based on innovative UK technology and is manufactured in the UK are important selling points for customers in the UK, EU and elsewhere,” he added.

Read more: Rio Tinto buys Argentina-based lithium project for 5m

Rate this article

The difference between trading assets and CFDs
The main difference between CFD trading and trading assets, such as commodities and stocks, is that you don’t own the underlying asset when you trade on a CFD.
You can still benefit if the market moves in your favour, or make a loss if it moves against you. However, with traditional trading you enter a contract to exchange the legal ownership of the individual shares or the commodities for money, and you own this until you sell it again.
CFDs are leveraged products, which means that you only need to deposit a percentage of the full value of the CFD trade in order to open a position. But with traditional trading, you buy the assets for the full amount. In the UK, there is no stamp duty on CFD trading, but there is when you buy stocks, for example.
CFDs attract overnight costs to hold the trades (unless you use 1-1 leverage), which makes them more suited to short-term trading opportunities. Stocks and commodities are more normally bought and held for longer. You might also pay a broker commission or fees when buying and selling assets direct and you’d need somewhere to store them safely.
Capital Com is an execution-only service provider. The material provided on this website is for information purposes only and should not be understood as an investment advice. Any opinion that may be provided on this page does not constitute a recommendation by Capital Com or its agents. We do not make any representations or warranty on the accuracy or completeness of the information that is provided on this page. If you rely on the information on this page then you do so entirely on your own risk.

Still looking for a broker you can trust?

Join the 570.000+ traders worldwide that chose to trade with Capital.com

1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading